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Questions about endocrine disruption and
aberrant brain function still seem lodged in
two separate toxicological universes. One
recent example is a bulletin from the Agency
for Toxic Substances and Disease Registry
(1). In summarizing its revised assessment of
polychlorinated biphenyl (PCB) toxicity, it
assigns developmental neurotoxicity to the
section titled “Neurodevelopmental
Studies.” Under another rubric, the “New
Endocrine Disruptor Section,” it points to
“. . . the effects of PCBs on breast cancer,
estrogenic and antiestrogenic activity, the
reproductive system, and thyroid glands.”
Apparently the bulletin’s authors failed to
connect the neurotoxic properties of PCBs
with their endocrine-disrupting properties.
This is hardly the only instance in which
the effects of hormones on other organ sys-
tems are discussed in isolation from their
effects on the brain. Much of the literature
on endocrine disruptors has reported on the
reproductive system and reproductive per-
formance. Disorders of reproduction in
experimental animals represent significant
threats to the sustainability of wild popula-
tions, of course, and imply potential hazards
to human health. The primary hazards to
humans, however, appear in less direct
guises. In their most subtle and insidious
form, they emerge as interference with the
course of brain development and resulting
aberrations in behavior. Some of these
aberrations appear as alterations of character-
istic differences between males and females
in nonreproductive behaviors.
Brain development is a tightly orches-
trated process. It proceeds through a
sequence of stages that continues long after
birth. And, pertinent to the theme of this
workshop, it is guided by hormones.
Gender-specific regional differentiation of
the brain and, ultimately, its expression in
behavior are guided by the gonadal hor-
mones. The process is delicately balanced,
however, and subject to interference by
drugs and environmental contaminants.
Although reproductive function is often
considered the predominant realm of behav-
ior served by gonadal hormones, appraising
the risks posed by environmental endocrine
disruptors requires that we ask a much
broader question: What are the implications
for nonreproductive behaviors? Males and
females, both human and otherwise, differ
signiﬁcantly in many aspects of performance.
If such differences are diminished, reversed,
or widened by perinatal chemical exposures,
a reasonable inference is that exposure inter-
fered with the modulatory effects of sex
hormones on brain development.
Data bearing on how environmental
chemicals influence sex differences in non-
reproductive behaviors and their underlying
mechanisms are rather sparse. McGivern and
Handa (2) argue forcefully that this question
has not been addressed adequately in the
drug abuse literature. They note that
“[k]nowing the performance of an animal
with respect to a nonreproductive behavior
does not necessarily predict its behavior
potentials for reproductive behaviors.” Their
reviews of the cocaine, opiate, marijuana,
nicotine, and alcohol literature substantiate
their argument. In the case of nicotine, for
example, they point to a small set of data
indicating that nicotine exposure of the male
fetus, at levels seen in pregnant smokers,
results in demasculinized behavior patterns
in adulthood and note that the implications
for more complex behaviors have not been
pursued. Such questions warrant extensive
exploration because of their influence on
public health policy.
Roots of Sex Differences 
in Behavior
In humans, sex differences in cognitive
behaviors are subtle and described primarily
by statistical measures. As groups, males and
females differ on average in specific cogni-
tive approaches and abilities, although indi-
viduals cannot be assigned gender labels
based, say, on neuropsychological test per-
formance. As populations, females tend to
score better on tests of verbal ability,
whereas males as a group tend to score
better on tests of spatial ability (3).
Although the basis of such differences
has stirred debate, with some critics assert-
ing that their roots are cultural rather than
biological (4), the evidence for biological
substrates is compelling. Sexual dimor-
phisms in brain structure in rats include the
size of the medial preoptic nucleus and its
sexually dimorphic nucleus (SDN-POA) of
the hypothalamus, which is considerably
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larger in males (5,6), and the dentate gyrus
granule cell layer of the hippocampus, also
larger in males (7). In mice, as well, the
granule cell layer of the hippocampus is
larger in males than in females and is also
larger in the right hemisphere than in the
left in males but not in females (8).
Significant sexual dimorphism in cortical
lateralization is also apparent in rodents;
male brains tend to exhibit right hemisphere
dominance, whereas female brains tend to
be more symmetrical (9,10). Sex differences
are seen in the bed nucleus of the stria ter-
minalis in rodents, which also is inﬂuenced
during development by gonadal steroids
(11). Human brains also show evidence of
sexual dimorphisms; a structure correspond-
ing to the SDN-POA is larger in males (12),
but, although presumably involved in male
sexual behavior, the connection has yet to
be confirmed. Cortical lateralization in
humans also may be sex-linked, with indica-
tions that, as in rodents, males show more
asymmetry (13).
The examples above, drawn from an
extensive literature, are meant simply to
illustrate that morphological differences
between the sexes have been extensively doc-
umented. Such differences, although slight
in some cases, are clearly relevant to environ-
mental health issues. They may help explain
the findings that males display a higher
prevalence of mental retardation, learning
disabilities, and attention-deﬁcit/hyperactiv-
ity disorder than females, that boys recover
function less readily from brain damage than
girls, and that women, on the other hand,
exhibit a higher incidence and prevalence of
dementia than men (14).
Because sexual differentiation of the
brain is guided primarily by the actions of
gonadal hormones but with thyroid hor-
mones involved as well (15), disturbing the
appropriate balance of these hormones dur-
ing development by exogenous agents will
produce morphological, neurochemical, and
behavioral abnormalities. McEwen (16) suc-
cinctly noted that the brain–endocrine axis is
in a delicately balanced state during develop-
ment: “Exogenous mimics can play havoc
with brain development and differentiation.”
This delicate balance is forcefully illus-
trated by the behavioral correlates of the
genetic virilizing disease congenital adrenal
hyperplasia. Females with this disorder,
which exposes them to high levels of andro-
gens during gestation as well as postnatally,
exhibit behavioral patterns indicating both
masculinization and defeminization (17).
For example, as children, they tend to show
male preferences for toys; they are more
aggressive than normal girls; they show
greater spatial abilities; and they are less
interested in feminine appearance. Over a
broad range of behaviors, development
becomes more prototypically male because of
a shift in the balance of gonadal hormones.
McEwen’s statement supports a com-
pelling argument for giving sexually dimor-
phic behaviors a major role in assessing the
developmental neurotoxicity of environmen-
tal chemicals, especially those identiﬁed, on
the basis of other data, as endocrine disrup-
tors. Experiments with PCBs and dioxins
(exempliﬁed by 2,3,7,8-tetrachlorodibenzo-
p-dioxin [TCDD]) offer a variety of exam-
ples indicating that, during early brain
development, males and females are differen-
tially susceptible to their effects, a differenti-
ation that provides important clues about
their toxic mechanisms.
Sex Differences in Behavioral
Toxicity
Spatial discriminations are frequently cited
as among the behaviors distinguishing male
and female rodents as well as human males
and females (18,19). PCBs and TCDD have
been studied with devices and approaches
designed to examine their inﬂuence on such
behaviors when administered perinatally. In
one study (20), the ortho-substituted con-
geners PCB 28, PCB 118, and PCB 153
were administered to pregnant rats by gavage
on gestational days (GD) 10–16. Neither
male nor female offspring of PCB-treated
dams displayed differences from controls in
performance on a radial arm maze. Testing
on a spatial alternation task, implemented
on a T-maze and using delays of 0, 15, 25,
or 40 sec, revealed slower acquisition by
female offspring exposed to one of the three
congeners. Males remained unaffected.
Because impairment occurred at all delays,
the authors interpreted the results to indicate
a learning or attentional deficit rather than
memory impairment.
The same investigators (21) studied per-
formance on the two tasks after prenatal
exposure to TCDD and to the coplanar
compounds PCB 77 and PCB 126. Unlike
the previous results with ortho-substituted
PCBs, in this experiment they found
decreased errors on radial maze performance,
particularly in male offspring, after TCDD
administration (totals of 175 and 700 ng/kg
administered during GD 10–16), perhaps
because the exposed animals adopted a
stereotyped behavioral pattern similar to
those displayed by rats with nigrostriatal
lesions. In a subsequent study (22), male off-
spring (700 ng/kg on GD 10–16) again
showed improved performance on the radial
arm maze, but both sexes showed deﬁcits on
a reversal learning task, which, unlike the
radial arm maze, does not reinforce a stereo-
typed response strategy. A further explo-
ration of these findings (23) used both the
8-arm maze studied earlier and a 12-arm
maze with only eight arms baited and
administered two doses, 700 and 1,400
ng/kg, over GD 10–16. This later study
again showed enhanced male performance
on the 8-arm maze but only at the lower
dose. On the 12-arm maze, neither sex dif-
fered from controls. The authors suggest that
improved performance on the 8-arm maze
may have arisen from the stereotyped pat-
terning rather than improved spatial learning
or memory.
These discrepant results led the investi-
gators (24) to examine performance on the
12-arm maze in offspring exposed from GD
6 to postnatal day (PND) 21 to the PCB
blend Aroclor 1254, whose constituents are
composed overwhelmingly of ortho-substi-
tuted congeners. They baited only eight of
the arms with food so that, for efﬁcient per-
formance, the rats had to learn the pattern.
Figure 1 shows the number of reference
memory errors over the course of the experi-
ment. Working memory errors showed a
similar pattern. The ﬁgure highlights asymp-
totic (i.e., steady state) performance and
shows contrasting responses to developmen-
tal exposure. During this period, in which
some sessions were also used for drug chal-
lenges, exposed males committed more
errors than control males during the no-drug
sessions. Treated female rats committed
fewer errors than controls. Male–female dif-
ference scores were neither calculated nor
analyzed, unfortunately. Had they been, the
authors might have found more support for
their speculation that endocrine disruption
underlies these effects.
This complex pattern of results indicates
the need to carefully consider the question
of experimental design. Multiple doses plus
multiple end points, when interactions with
sex also are planned as part of the statistical
analyses, mean that experimenters must try
to provide enough statistical power, by
using large enough subject groups, to enable
such analyses.
The developmental neurotoxicity of
Aroclor 1254 has also been the subject of
further studies. Building on the theme of
spatial learning, offspring exposed (as above)
to 6 mg/kg daily from GD 6 to PND 21
were tested in a situation designed to meas-
ure their ability to switch positions between
two levers in an operant test chamber (25).
They were reinforced with a food pellet for
pressing the correct lever. When the correct
position switched sides, they then had to
relearn the correct location. Exposed male
offspring made more errors than controls on
the first of five reversals, whereas exposed
females made more errors on later reversals;
that is, they reached a lower level of asymp-
totic performance than controls. Although
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the authors attempted an analysis of these
response patterns, they did not use the kind
of mathematically rigorous method needed
to quantify serial dependencies. One useful
method (26) consists of specifying optimal
response sequences, calculating the degree to
which the maximizing criterion is met, and
plotting the latter over sessions as a measure
of acquisition. Another is to use autocorrela-
tion functions to determine serial dependen-
cies (27). The data do reflect, however, sex
differences in error patterns in the exposed
offspring, explanations which point to
endocrine inﬂuences.
Sensory Function
Another aspect of sex differences in behavior
produced by developmental exposure to
Aroclor 1254 appeared in an experiment
directed at sensory effects (28). Because of
other data suggesting PCB effects on the
visual system (29), which, incidentally,
revealed sex differences, rats exposed to 1 or 6
mg/kg from GD 6 to PND 21 were trained
to perform a signal detection task for the
measurement of both absolute and relative
brightness thresholds. Part of the training
involved an autoshaping procedure designed
to train the subjects to press the lever in the
chamber for food. Once the rat learned to
retrieve automatically delivered food pellets,
the next step associated the lever with food
pellet delivery. Figure 2 shows striking differ-
ences between males and females during this
period. Control female offspring emitted
fewer responses than males, but males and
females differed in how exposure affected
them. Exposed females responded at higher
rates than controls, whereas exactly the oppo-
site pattern appeared in the males. Because,
as shown in Figure 2, the dose–response
function in males was U-shaped, the authors
remarked that “[t]he effect in the females was
PCB dose dependent, whereas in the males it
was not.” This statement fails to acknowl-
edge that, as often noted, U-shaped functions
are frequently seen in toxicology (30). Such
phenomena are especially common in studies
of endocrine function. For example, in stud-
ies of prostate enlargement in mice due to
fetal exposure to estradiol or diethylstilbe-
strol, prostate weight ﬁrst increased and then
decreased with dose, resulting in an inverted-
U dose–response relationship (31). The study
that relied on only a single 6-mg/kg dose of
Aroclor 1254, described above (25), may
have excluded a useful result for that reason.
The results of this experiment (28) also
showed sexually dimorphic effects on sensory
function. Aroclor 1254 exposure during
development produced a decrease in sensitiv-
ity for females compared with their controls.
In males, exposure produced an increase in
sensitivity. The authors interpreted the results
of both phases of the behavioral studies as
feminization of the males and masculinization
of the females, a hypothesis grounded in the
superficially paradoxical effects of gonadal
hormones administered perinatally. That is,
androgens at certain times may feminize male
behavior, whereas estrogens may masculinize
female behavior. Aroclor 1254 is a complex
mixture primarily of ortho-substituted PCBs.
This property of Aroclor 1254 may explain
why, in another study (32), which assayed
visual function after developmental exposure
to the coplanar PCB 126, no significant
effects appeared either on thresholds or on
male–female differences.
Schedule-Controlled Operant
Performance
Schedule-controlled operant behavior has
enjoyed wide applicability in behavioral
pharmacology and toxicology because of its
ability to answer questions on how an organ-
ism’s behavior changes in response to the
consequences of the behavior (33). In typical
operant situations, normal male rats tend to
emit higher overall response rates than
females. Ratio schedules, which require a
speciﬁed number of responses for reinforce-
ment delivery, appear to tax a food-moti-
vated function labeled as “behavioral
perseverance” (34). Male rats display food-
motivated perseverance across a number of
behavioral manipulations. Male rats spend
more time than females holding down a
lever if holding is food reinforced (35). Male
rats are more likely than females to continue
to respond on a lever that no longer pro-
duces reinforcement (36). Also, under ratio
schedules, the performance of castrated
males resembles the lower response rates
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more typical of control females, suggesting
the inﬂuence of testosterone (37).
A recent study from our laboratory,
based on schedule-controlled operant behav-
ior, evoked distinctly different patterns of
responding in rat offspring exposed to
TCDD on GD 8 (38). Pregnant dams were
given oral doses of 0, 20, 60, and 180 ng/kg
TCDD on GD 8. Offspring (one male and
one female from each litter) then underwent
preliminary lever-press training at 90 days of
age for food pellet reinforcement in a two-
lever operant chamber. Only one of the
levers was active during the experiment.
During the ﬁrst phase of the experiment, the
subjects progressed every 4 days through a
sequence of fixed ratio (FR) contingencies
(1, 6, 11, 21, 31, 41, 51, 61, and 71). That
is, they began the series with FR1, requiring
only a single lever press to trigger delivery of
a food pellet. After 4 days, they advanced to
FR6, requiring six lever presses to deliver a
food pellet, and so forth until they reached
the final value of FR71, which required 71
lever presses to trigger pellet delivery.
At the completion of the incremental FR
phase, we introduced a multiple schedule.
FR11 comprised one component. The other
component was a differential reinforcement
of low rate (DRL) schedule. Here, successive
lever presses had to be separated by 10 sec or
more to secure reinforcement. The two com-
ponents alternated and were distinguished
by a house light that remained on during the
FR segment. Generally, males respond at a
higher rate than females on both ratio and
DRL schedules, but females typically earn
more reinforcements on the latter because
they emit fewer premature responses.
Figure 3 shows FR performance during
the multiple schedule phase. Exposed males
and females moved in opposite directions.
Exposed females responded at higher rates
than controls; exposed males responded at
lower rates. DRL rates moved in the same
direction as FR rates. For both components,
the statistical analysis indicated a signiﬁcant
sex-by-treatment interaction. We plotted
these interactions by fitting second-order
polynomial functions to the difference scores,
as shown in Figure 4. The analysis of vari-
ance of sex differences documented a signiﬁ-
cant quadratic trend (p = 0.01). The plots
show that, although the mean rates for con-
trol males exceeded those for control females,
the relationship changed across doses. For
example, the 60-ng/kg females responded at
higher rates than the 60-ng/kg males.
On the basis of these differences, we cal-
culated benchmark doses with the help of
the U.S. Environmental Protection Agency’s
Benchmark Dose (BMD) software. The
BMD10 for continuous data is equivalent to
an ED10 (10% effective dose) and is used
much like an NOAEL (no observed adverse
effect level). The 95% lower bound, for
example, can be divided by an uncertainty
factor such as 100 to provide a reference
dose or acceptable daily intake. When we
calculated BMD10 values for these data, we
found them to be 2.77 ng/kg with a lower
95% lower bound of 1.81 ng/kg for FR rate
and 2.97 with a lower bound of 2.02 for
DRL rate. Human body burdens of TCDD
equivalents were calculated in 1995 to be
about 13 ng/kg (39). That is, basing our cal-
culations on male–female difference scores,
we see values considerably below those of
current human body burdens even without
applying a safety or uncertainty factor.
The shape of the dose–response function
in this study replicates one we observed in an
earlier study (40) that tested only females in
an attempt to determine a correlation
between estrous cycle phase and the willing-
ness to press a lever for access to a running
wheel. Although no correlation emerged, we
recorded a similar, significant, U-shaped
dose–effect relationship.
Implications
Even this limited survey demonstrates the
power of using sexually dimorphic behaviors
to illuminate the scope of adverse develop-
mental consequences produced by chemicals
with endocrine-disrupting properties. The
survey emphasized nonreproductive behav-
iors because so much of the disruptor litera-
ture has focused on reproductive function,
perhaps because of its origins in questions
about environmental estrogens. The scale of
such questions needs to be enlarged substan-
tially to encompass those functions most
critical in human life—functions that
depend on intact nervous system develop-
ment. Programs to try to identify potential
endocrine disruptors need to include behav-
ioral assays and analyses of the size of sex dif-
ferences if they are to provide adequate
information about health risks.
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Figure 3. Rate of reinforcement (food pellet delivery) in (A) male and (B) female offspring of rat dams
administered TCDD on GD 8. The charts depict performance on the FR component of a multiple reinforce-
ment schedule. TCDD lowered male rates and elevated female rates. Modiﬁed from Hojo et al. (38).Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 3 | JUNE 2002 391
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